A retrospective analysis omalizumab treatment patterns in patients with chronic spontaneous urticaria : a real-world study in Belgium

Background: Chronic spontaneous urticaria (CSU) is characterized by the repeated occurrence of persistent hives and/or angioedema for ≥6 weeks, without specific external stimuli. H1-antihistamines have long been the standard of care of CSU, but many patients remain uncontrolled even at 4× the approved dose. Add-on therapy with omalizumab has proven effective in clinical trials, but little is known about omalizumab treatment in Belgium. Objective: To collect real-world clinical data on omalizumab treatment in adults with CSU in Belgium. Methods: This was an observational, retrospective chart re... Mehr ...